BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Cash Flow
NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.07M | -2.80M | -7.37M | -14.96M | -8.65M | |||
| Depreciation Amortization | 76.80K | 73.40K | 72.50K | 6.00K | N/A | |||
| Change In Working Capital | -658.70K | 39.80K | -941.70K | 724.10K | 674.60K | |||
| Other non cash items | -872.60K | 838.60K | 1.22M | 647.70K | 656.80K | |||
| OPERATING CASH FLOW | -2.52M | -1.85M | -7.02M | -13.59M | -7.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -91.50K | -89.70K | -86.10K | -7.20K | N/A | |||
| Stock Issued/Repurchased | 52.15M | 900.30K | 2.30M | 6.00M | 27.84M | |||
| Other Financing Activity | N/A | 0.00 | -27.00K | -800.00K | -1.79M | |||
| FINANCING CASH FLOW | 51.97M | 810.60K | 2.19M | 5.20M | 26.06M | |||
| Exchange Rate Effect | 1.68M | 11.70K | -45.40K | 258.80K | 223.80K | |||
| CHANGE IN CASH | 51.13M | -1.03M | -4.88M | -8.13M | 18.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.52M | -1.85M | -7.02M | -13.59M | -7.32M | |||
| FREE CASH FLOW | -2.52M | -1.85M | -7.02M | -13.59M | -7.32M | |||
All data in CAD